Your Complete Guide to Global Clinical Research and GCP Compliance
Trial Master File (TMF) Basics: Building an Inspection-Ready eTMF That Proves Compliance TMF Fundamentals: How to Build, Run, and Defend an Inspection-Ready eTMF Purpose, Scope, and the Regulatory Frame for the TMF The Trial Master File (TMF) is the documentary evidence that your clinical trial was designed, conducted, and reported in accordance with Good Clinical…
Budgeting & Contracts 101: Building Defensible Clinical Trial Budgets and Agreements Budgeting and Contracting for Clinical Trials: How to Price, Negotiate, and Document Without Surprises Funding Fundamentals, Legal Groundwork, and Accountability Lines Money and risk are inseparable in clinical development. A sound budget and well-constructed agreements translate scientific ambition into executable, compliant operations. For U.S.,…
Read More “Budgeting & Contracts 101: Building Defensible Clinical Trial Budgets and Agreements” »
Site vs. Sponsor Perspectives: Aligning Incentives, Workflows, and Oversight in Clinical Trials Bridging Site and Sponsor Priorities for Faster, Cleaner, and Compliant Trials Two Lenses, One Study: Governance, Incentives, and Accountability Clinical studies succeed when sponsors and sites see the same trial through different lenses and still move in step. Sponsors must deliver reliable evidence…
Phase 1 Study: Comprehensive Guide to Planning and Executing Phases I–IV & Post-Marketing Studies Comprehensive Guide to Planning and Executing Phase 1 Study and Subsequent Clinical Trial Phases This tutorial provides clinical operations, regulatory affairs, and medical affairs professionals with a detailed, step-by-step framework for planning and executing a phase 1 study and the subsequent…
Read More “Phase 1 Study: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »
Lecanemab Phase 3: Comprehensive Guide to Planning and Executing Clinical Trial Phases I–IV and Post-Marketing Studies Planning and Executing Lecanemab Phase 3 and Beyond: A Step-by-Step Guide to Clinical Trial Phases I–IV and Post-Marketing Studies In this article, we provide a detailed, stepwise tutorial on planning and executing clinical trial phases I through IV, including…
Read More “Lecanemab Phase 3: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »
Giredestrant Phase 3: A Step-by-Step Guide to Planning and Executing Phases I–IV and Post-Marketing Studies Comprehensive Tutorial on Planning and Executing Giredestrant Phase 3 and Subsequent Clinical Trial Phases This article provides a detailed, step-by-step regulatory tutorial on planning and executing clinical trials for giredestrant phase 3, covering Phases I through IV and post-marketing studies….
Read More “Giredestrant Phase 3: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »
Lanifibranor Phase 3: Comprehensive Guide to Planning and Executing Clinical Trial Phases I–IV and Post-Marketing Studies Planning and Executing Lanifibranor Phase 3 and Beyond: A Step-by-Step Guide to Clinical Trial Phases I–IV and Post-Marketing Studies This article provides a detailed, regulatory-focused tutorial on planning and executing clinical trial phases I through IV, including post-marketing studies,…
Read More “Lanifibranor Phase 3: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »
Brensocatib Phase 3: Stepwise Guide to Planning and Conducting Clinical Trial Phases I–IV and Post-Marketing Studies Comprehensive Tutorial on Planning and Executing Brensocatib Phase 3 and Subsequent Clinical Trial Phases This article provides a detailed, step-by-step regulatory tutorial on planning and executing clinical trial phases I through IV, including post-marketing studies, with a focus on…
Read More “Brensocatib Phase 3: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »
Als Phase 3 Trials: Comprehensive Guide to Planning and Executing Phases I–IV and Post-Marketing Studies Planning and Executing Als Phase 3 Trials and Beyond: A Step-by-Step Guide for Global Clinical Teams Als phase 3 trials represent a critical juncture in the clinical development pathway, requiring meticulous planning and execution to meet stringent regulatory standards across…
Read More “Als Phase 3 Trials: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »
Phase 3B Clinical Trial: How to Plan and Execute Phases I–IV & Post-Marketing Studies Comprehensive Guide to Planning and Executing Phase 3B Clinical Trials and Beyond The phase 3b clinical trial represents a critical juncture in drug development, bridging the gap between confirmatory Phase III studies and post-marketing activities. This tutorial provides clinical operations, regulatory…
Read More “Phase 3B Clinical Trial: How to Plan and Execute Phases I–IV & Post-Marketing Studies” »